Related Experiment Videos
Fertility considerations in nerve-sparing retroperitoneal lymph-node dissection
R S Foster1, A McNulty, L R Rubin
1Indiana University Medical Center, Department of Urology, Indianapolis 46202-5250.
World Journal of Urology
|January 1, 1994
Summary
Nerve-sparing retroperitoneal lymph-node dissection (RPLND) preserves ejaculation function in testicular cancer patients. This nerve-preserving approach maintains fertility potential, with many patients successfully fathering children post-surgery.
Area of Science:
- Urology
- Oncology
- Reproductive Medicine
Background:
- Testicular cancer treatment, including retroperitoneal lymph-node dissection (RPLND), can impact male fertility.
- Nerve-sparing RPLND aims to preserve ejaculatory function, but its impact on overall fertility potential requires further assessment.
Purpose of the Study:
- To evaluate the fertility status of clinical stage A testicular cancer patients undergoing nerve-sparing RPLND.
- To determine if preserving nerve function during RPLND is clinically significant for maintaining reproductive capability.
Main Methods:
- Fertility assessment using standard semen analysis in clinical stage A patients.
- Post-RPLND survey to assess pregnancy attainment in partners of treated patients.
Main Results:
- Approximately 75% of non-seminomatous testicular cancer patients in clinical stage A demonstrated fertility potential via semen analysis.
- Of patients attempting pregnancy post-RPLND, 76% reported successful conception.
Conclusions:
- Nerve-sparing RPLND effectively maintains fertility potential in clinical stage I testicular cancer patients.
- The fertility potential preserved by nerve-sparing RPLND is clinically significant, enabling many patients to achieve biological fatherhood.